Data Management and Biometrics at Celerion bridges the gap between medical practice and laboratory science by assessing the safety of drug products to maximize drug effects and minimize side effects.
The scientists at Celerion design efficient, scientifically sound clinical studies; analyze and interpret data from these studies; and use the knowledge obtained to design the next study in the drug-development cycle. The scientists provide the following:
- Estimate optimal dosing for human studies based on animal or human results
- Design early clinical research studies and write protocols to evaluate safety and PK/PD
- Analyze and interpret data from clinical studies
- Communicate results from human studies for regulatory filings
Celerion has one of the most experienced Data Management and Biometrics teams in the industry, with over 120 staff operating across five global locations in North America and Europe and nearly 40 years of experience. The team produces more than 200 clinical study reports annually and has developed over 5,000 protocols. Data Management and Biometrics offers expertise in the following areas: